{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:26:26Z","timestamp":1777418786586,"version":"3.51.4"},"reference-count":22,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To report 6 cases of osteonecrosis in HIV-infected patients treated with highly active antiretroviral therapy (HAART) and compare the observed risk factors with those of published cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CASE SUMMARIES<\/jats:title>\n                    <jats:p>\n                      Osteonecrosis was diagnosed between 1999 and 2002 in 6 of 417 HIV-infected patients in our department of infectious diseases. At the time of diagnosis, mean patient age was 42 years, and 5 patients had developed AIDS. Mean CD4+ lymphocyte count was 563.5 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      and viral load was undetectable (&lt;50 copies\/mL) in 5 patients. The patients\u2019 mean body mass index was 22.5 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . Four had lipodystrophy. All were receiving HAART, including a protease inhibitor in 4 patients; the remaining 2 patients had a history of protease inhibitor treatment. Median time from the first antiretroviral therapy to osteonecrosis diagnosis was 46.5 months. Established risk factors were the use of corticosteroids in 2 patients and dyslipidemia in all patients. All of the patients developed pain and functional impotence of the hip or ankle joints. Osteonecrosis of the hip was bilateral in 4 cases. Three patients required surgical intervention, all of whom had favorable outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION<\/jats:title>\n                    <jats:p>HIV-infected patients are at a higher risk for the development of osteonecrosis and are more likely to be exposed to predisposing factors to its development. The HAART implication as a predisposing factor remains controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>The pathogenesis of osteonecrosis in HIV-infected individuals may be multifactorial; the reasonable approach for clinicians consists of treating concomitant predisposing conditions that might further cause osteonecrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1e154","type":"journal-article","created":{"date-parts":[[2004,10,26]],"date-time":"2004-10-26T21:58:02Z","timestamp":1098827882000},"page":"2050-2054","source":"Crossref","is-referenced-by-count":22,"title":["Osteonecrosis in Six HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy"],"prefix":"10.1177","volume":"38","author":[{"given":"Aur\u00e9lie C","family":"Molia","sequence":"first","affiliation":[{"name":"Aur\u00e9lie C Molia PharmD, Clinical Pharmacist, Pharmacovigilance Regional Center, CHU, Reims, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Strady","sequence":"additional","affiliation":[{"name":"Christophe Strady MD, Clinical Specialist, Department of Infectious Diseases, CHU, Reims"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Rouger","sequence":"additional","affiliation":[{"name":"Christine Rouger MD, Clinical Specialist, Department of Infectious Diseases, CHU, Reims"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle M","family":"Beguinot","sequence":"additional","affiliation":[{"name":"Isabelle M Beguinot MD, Clinical Specialist, Department of Infectious Diseases, CHU, Reims"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Berger","sequence":"additional","affiliation":[{"name":"Jean-Luc Berger MD, Clinical Specialist, Department of Infectious Diseases, CHU, Reims"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry C","family":"Trenque","sequence":"additional","affiliation":[{"name":"Thierry C Trenque MD PhD, Director, Pharmacovigilance Regional Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2004,12,1]]},"reference":[{"key":"bibr1-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00003"},{"key":"bibr2-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200009080-00026"},{"key":"bibr3-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200003100-00005"},{"key":"bibr4-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1086\/319745"},{"key":"bibr5-aph.1E154","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-198062050-00014"},{"key":"bibr6-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1007\/s150100070049"},{"key":"bibr7-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-7071(99)00151-5"},{"key":"bibr8-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1086\/322779"},{"key":"bibr9-aph.1E154","first-page":"1","volume":"15","author":"Monier P","year":"2003","journal-title":"HIV Clin"},{"key":"bibr10-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199906180-00025"},{"key":"bibr11-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200202150-00021"},{"key":"bibr12-aph.1E154","doi-asserted-by":"publisher","DOI":"10.3928\/0147-7447-20010301-19"},{"key":"bibr13-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1086\/317503"},{"issue":"17","key":"bibr14-aph.1E154","first-page":"1","volume":"41","author":"Centers for Disease Control and Prevention","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr15-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200009010-00003"},{"key":"bibr16-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200109010-00017"},{"key":"bibr17-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1086\/367566"},{"key":"bibr18-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1086\/321826"},{"key":"bibr19-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1089\/108729101750301933"},{"key":"bibr20-aph.1E154","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-1-200207020-00008"},{"key":"bibr21-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1089\/108729100416614"},{"key":"bibr22-aph.1E154","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1E154","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1345\/aph.1E154","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1E154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:08:16Z","timestamp":1777374496000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1E154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1345\/aph.1E154"],"URL":"https:\/\/doi.org\/10.1345\/aph.1e154","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}